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ARTICLE
Aortic pathology from protein kinase G activation is
prevented by an antioxidant vitamin B12 analog
Gerburg K. Schwaerzer1,4, Hema Kalyanaraman1,4, Darren E. Casteel1, Nancy D. Dalton1, Yusu Gu1,
Seunghoe Lee1, Shunhui Zhuang1, Nisreen Wahwah1, Jan M. Schilling2, Hemal H. Patel2, Qian Zhang1,
Ayako Makino1, Dianna M. Milewicz3, Kirk L. Peterson1, Gerry R. Boss1 & Renate B. Pilz 1
People heterozygous for an activating mutation in protein kinase G1 (PRKG1, p.Arg177Gln)
develop thoracic aortic aneurysms and dissections (TAAD) as young adults. Here we report
that mice heterozygous for the mutation have a three-fold increase in basal protein kinase G
(PKG) activity, and develop age-dependent aortic dilation. Prkg1R177Q/+ aortas show
increased smooth muscle cell apoptosis, elastin fiber breaks, and oxidative stress compared
to aortas from wild type littermates. Transverse aortic constriction (TAC)—to increase wall
stress in the ascending aorta—induces severe aortic pathology and mortality from aortic
rupture in young mutant mice. The free radical-neutralizing vitamin B12-analog cobinamide
completely prevents age-related aortic wall degeneration, and the unrelated anti-oxidant N-
acetylcysteine ameliorates TAC-induced pathology. Thus, increased basal PKG activity
induces oxidative stress in the aorta, raising concern about the widespread clinical use of
PKG-activating drugs. Cobinamide could be a treatment for aortic aneurysms where oxidative
stress contributes to the disease, including Marfan syndrome.
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Aortic aneurysms account for 1–2% of deaths in Westerncountries, and despite improvements in surgical repair,morbidity and mortality remain high, especially with
thoracic aortic aneurysms and dissections (TAAD)1,2. Blood
pressure control with β-adrenergic or angiotensin receptor
blockers modestly improves prognosis1–3. The thoracic aortic
pathology in TAAD is characterized by progressive elastin fiber
fragmentation, smooth muscle cell (SMC) loss, and collagen
accumulation, leading to aortic dilation and/or rupture2. Muta-
tions causing hereditary TAAD affect proteins regulating trans-
forming growth factor-β (TGF-β) signaling, e.g., TGF-β
receptors-1 and -2 in Loeys–Dietz syndrome and fibrillin-1 in
Marfan syndrome, or components of the SMC contractile appa-
ratus, e.g., SM-α-actin (ACTA2) and myosin heavy chain-11
(MYH11)2,4. Aortic pathology has been attributed to SMC de-
differentiation and activation of stress pathways leading to
increased production of tissue-destructive matrix metalloprotein-
ases (MMPs)2,5–9.
PKG1 mediates vasodilation in response to nitric oxide (NO)-
induced cGMP synthesis10,11. It also regulates SMC differentia-
tion, preventing a de-differentiated, proliferative phenotype after
vascular injury12–15. Excess NO may contribute to aortic disease
in Marfan syndrome and other forms of TAAD, but it is
unknown whether NO’s effects are mediated by PKG16. Case
reports suggest that long-term use of PKG-activating drugs—e.g.,
phosphodiesterase-5 inhibitors for erectile dysfunction or pul-
monary hypertension—may increase risk for acute aortic dissec-
tions17–21.
We previously identified a recurrent gain-of-function mutation
in PRKG1 as a cause of early-onset thoracic aortic disease in
humans22. Here we show that mice carrying this mutation
recapitulate the human disease, and that pathological changes in
the aorta are, at least in part, caused by oxidative stress, since they
are prevented by treating the mice with two structurally- and
mechanistically- unrelated anti-oxidants.
Results
PKG activity and blood pressure in Prkg1R177Q/+ mice. The
PRKG1,p.Arg177Gln mutation associated with familial TAAD is
located in the first cGMP-binding domain of the kinase and
causes constitutive activation of both PKG1α and 1β isoforms
(Supplementary Fig. 1a–f). The catalytic domain is unchanged,
and the mutant protein (hereafter referred to as PKG1RQ) is still
inhibited by the PKG-specific peptide DT2 (Supplementary
Fig. 1g)23. About 50% of homozygous mice (referred to as
Prgk1RQ/RQ) died within the first 6 weeks of life from gastro-
intestinal dysfunction, with dilated esophagus, stomach, and
bowel. Surviving Prkg1RQ/RQ mice were underweight and smaller
compared to wild-type (WT) littermates, even when given liquid
food after weaning (Supplementary Fig. 1h, i). We focused on
heterozygous Prkg1RQ/+ mice, because heterozygous humans
manifest disease22. Prkg1RQ/+ mice appeared healthy, weighed
the same as WT littermates, and had no obvious developmental
abnormalities of the aorta (Supplementary Fig. 1h–l).
PKG1 protein and cGMP-stimulated PKG activity were the
same in aortas from Prkg1RQ/+ mice and their WT littermates,
but basal PKG activity in the absence of cGMP was about three-
fold higher in aortas from mutant mice, when measured with a
peptide substrate (Fig. 1a) or by assessing phosphorylation of
vasodilator-stimulated phosphoprotein (pVASP; Fig. 1b).
Although the purified mutant enzyme is fully active in the
absence of cGMP (Supplementary Fig. 1f), basal PKG activity in
heterozygous aortas was <50% of total cGMP-stimulated activity
(Fig. 1a), likely because the wild-type enzyme inhibits the mutant
enzyme in a heterodimer22. Similar to the purified enzyme, basal
and cGMP-stimulated PKG activities in the aorta were largely
inhibited by DT2 (Fig. 1a).
Humans carrying the PRKG1R177Q mutation are generally
normotensive22, and consistent with this finding, Prkg1RQ/+ mice
had only modestly reduced systolic and diastolic blood pressures
compared to wild-type littermates, resulting in ~10 mmHg lower
mean arterial pressures during sleep and wake hours (Fig. 1c, d,
Supplementary Fig. 2a). Heart rate and pulse pressure were not
altered (Supplementary Fig. 2b, c). Thus, although acute PKG1
activation by NO/cGMP causes vasodilation and hypotension in
mice and humans11, a sustained increase in basal PKG1 activity
has a small effect on blood pressure.
We evaluated the physiologic consequences of the PKG1RQ
mutant protein by assessing contraction of aortic rings derived
from mutant and wild-type mice. The concentration of
prostaglandin F2α required to pre-contract rings was similar in
aortas from eight month-old-wild type and mutant mice (2.15 ±
0.17 versus 2.27 ± 0.86 μM; means ± SEM, n= 5 wild type and
mutant vessels, respectively). However, relaxation of the rings in
response to 8-CPT-cGMP or to acetylcholine—which is largely
NO-mediated24—was reduced in the mutant vessels compared to
wild type vessels (Supplementary Fig. 2d, e). These data are
consistent with higher basal, cGMP-independent PKG activity in
the aortas of heterozygous mice compared to wild-type mice,
resulting in smaller cGMP-induced increases in enzyme activity
(Supplementary Fig. 2f). Reduced NO bioavailability due to
oxidative stress in the Prkg1RQ/+ mice (described below) may
contribute to decreased acetylcholine-induced aortic relaxation,
but this requires further investigation.
Age-dependent pathologic changes in Prkg1RQ/+ aortas. The
Prkg1RQ/+ mice had normal thoracic aorta dimensions at
4–6 months of age, but moderate aortic dilation became apparent
at 12 months, with similar phenotypic changes in males and
females (Fig. 1e, f, Supplementary Fig. 2g–i). While the aortas of
young Prkg1RQ/+ mice were histologically normal, the aortas of
12-month-old mutant mice had increased elastin fiber breaks,
SMC apoptosis and loss of SMCs, and collagen accumulation in
the media layer; media thickness was similar as in WT mice
(Fig. 1g–j, Supplementary Fig. 2j). Thus, middle-aged Prkg1RQ/+
mice recapitulated aortic changes observed in patients hetero-
zygous for the PKGRQ mutation22,25.
Gene expression, oxidative stress, and MMP activity. Compared
to WT littermates, aortas from 4-month-old Prkg1RQ/+ mice
showed increased mRNAs encoding the SMC contractile proteins
Acta2,Myh11, and Tagln, and the transcription factor myocardin,
consistent with previous in vitro findings that PKG1 promotes a
differentiated, contractile SMC phenotype (Fig. 2a)12–14.
Expression of TGF-β1 and its target genes Ctgf, Serpine1, Eln, and
Nox4 were also increased in the mutant mice, while Col3a1
showed a modest non-significant increase; expression of the
proteoglycans lumican (Lum) and decorin (Dcn) was unchanged
(Fig. 2a, b). Increased TGF-β signaling occurs in other heritable
diseases with TAAD, including Marfan syndrome9,26,27. How-
ever, the basis of increased TGF-β signaling, and whether it has a
causative or compensatory role remains a matter of
debate2,3,5,9,28.
NADPH oxidase-4 (Nox4) mRNA was ~10-fold higher in
aortas from Prkg1RQ/+ compared to WT mice, but Nox2 was not
altered and Nox1 was below detection (Fig. 2b). Nox4 is regulated
primarily at the transcriptional level; the enzyme is constitutively
active and generates mainly hydrogen peroxide (H2O2), with
some superoxide (O2−)29. SMCs isolated from Prkg1RQ/+ aortas
produced more H2O2 than those from WT aortas, and aortas
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11389-1
2 NATURE COMMUNICATIONS |         (2019) 10:3533 | https://doi.org/10.1038/s41467-019-11389-1 | www.nature.com/naturecommunications
from Prkg1RQ/+ mice showed increased oxidative stress, evident
by increased dihydroethidium staining and DNA-, lipid-, and
protein-oxidation products; Prkg1RQ/+ mice additionally had
higher serum ascorbyl radical concentrations than WT mice
(Fig. 2c–g, Supplementary Fig. 3a, b). c-Jun N-terminal kinase
(JNK) appears important in the pathogenesis of TAAD, because
JNK upregulates MMPs and induces SMC apoptosis, and JNK
inhibitors reduce aortic aneurysms in Marfan mice and in other
mouse models of TAAD7,30–32. We found increased activity of
both JNK and MMPs in Prkg1RQ/+ compared to WT aortas
(Fig. 2h–j), consistent with JNK activation by H2O2 and via
MEKK1 activation by PKG1 (refs. 30,32–34).
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Effects of mutant PKG1RQ in human aortic SMCs. To study the
mechanism whereby the mutant PKG1RQ leads to biochemical
changes and changes in gene expression, we expressed the wild
type and mutant enzyme in primary human aortic SMCs at levels
2–3-fold above endogenous PKG (Fig. 3a). We found increased
basal PKG activity in cells expressing the mutant enzyme—con-
sistent with more of the mutant enzyme present than the endo-
genous enzyme; basal VASP phosphorylation was increased in
PKG1RQ-expressing cells, while cGMP-stimulated phosphoryla-
tion was similar in cells expressing wild type or mutant enzyme
(Fig. 3a, b). Cells expressing PKG1RQ showed increased expres-
sion of contractile genes, and TGF-β1 and its target genes,
including Nox4; expression of these genes was stimulated by
TGF-β in both control cells and PKGRQ-expressing cells (Fig. 3c,
d; Supplementary Fig. 4a). The PKG1RQ-expressing cells pro-
duced more H2O2 than control cells or cells expressing wild-type
PKG1, and shRNA silencing of Nox4 reduced H2O2 production
and NADPH oxidase activity to control levels; Nox2 shRNA had
minimal effects (Fig. 3e, f, Supplementary Fig. 4b–d). A NOX1/4
inhibitor (GKT137831)35 reduced H2O2 production in the
PKG1RQ-expressing cells to a level found in control cells (Fig. 3g).
These results indicate that NOX4 was the major source of excess
H2O2 in cells expressing the mutant kinase. The PKG1RQ-
expressing cells also showed higher basal and TGF-β-induced
JNK activation and DNA and protein oxidation than control cells,
recapitulating findings in Prkg1RQ/+ aortas (Fig. 3h–j, Supple-
mentary Fig. 4e, f). The PKG1RQ-induced increase in DNA oxi-
dation was largely prevented by DT2, indicating a requirement
for PKG activity; the pro-oxidant effect of PKG1RQ was
mimicked by Nox4 over-expression and blocked by GKT137831
(Fig. 3j, k).
PKG1RQ did not appear to regulate the Nox4 promoter via
TGF-β, because PKG1RQ-induced luciferase activity from a Nox4
promoter-luciferase reporter was not affected by an inhibitor of
TGF-β receptor-1 (ref. 36), although the drug prevented promoter
activation by TGF-β (Supplementary Fig. 4g). However, stimula-
tion of the Nox4 promoter required JNK activity and PKG1RQ
enhanced the stimulatory effect of c-Jun on the promoter,
suggesting that PKG1RQ stimulation of Nox4 transcription is
mediated by JNK/c-Jun (Supplementary Fig. 4h). Similarly, the
oxysterol 7-ketocholesterol increases Nox4 transcription in
human SMCs via activation of JNK/c-Jun37.
Expression of PKG1RQ in the human SMCs inhibited growth
factor-induced proliferation and induced apoptosis (Supplemen-
tary Fig. 5a–c), consistent with effects of NO/cGMP-induced
PKG1 activation in rodent SMCs15,32,38. The growth-inhibitory
and pro-apoptotic effects of PKG1RQ were partly prevented by
DT2 and GKT137831, and were mimicked by NOX4 over-
expression, suggesting they were in part mediated by NOX4-
induced oxidative stress (Fig. 3l–o). Phosphodiesterase-5 inhibi-
tors such as sildenafil increase intracellular cGMP concentrations
and activate PKG11. In the human aortic SMCs, sildenafil
increased VASP phosphorylation and induced JNK activation
when combined with low concentrations of an NO donor; the
drug combination also inhibited SMC proliferation, thus
mimicking some important effects of PKG1RQ (Supplementary
Fig. 5d–f).
Prevention of age-related aortic pathology by cobinamide. To
determine if reducing reactive oxygen species could prevent the
pathological changes that occur in the thoracic aortas of Prkg1RQ/+
mice, we treated mice with cobinamide (Cbi), a vitamin B12 analog
that scavenges free radicals and exhibits potent antioxidant prop-
erties39. Providing Cbi in the drinking water from age 6 to
12 months reduced oxidative stress markers and SMC apoptosis in
aortas of Prkg1RQ/+ mice to values in WT mice (Fig. 4a–c, Sup-
plementary Fig. 6a). Notably, the drug completely prevented aortic
dilation and SMC loss in the mutant mice, and reduced elastin
fiber breaks and media collagen content to levels in WT mice
(Fig. 4d–f, Supplementary Fig. 6b). In human SMCs, Cbi decreased
H2O2-induced JNK activation and protein oxidation, and it
reduced protein oxidation in PKG1RQ-expressing cells (Supple-
mentary Fig. 6c–e). Cbi had no effect on the activity of purified
PKG1RQ, nor did Cbi treatment of the mice affect PKG activity in
aortic extracts (Supplementary Fig. 7a, b). Thus, excess oxidative
stress appears responsible for aortic disease caused by constitutive
PKG1 activation.
Cbi had no significant effects in wild-type mice, and no
discernable toxicity, as judged by normal weight, clinical
appearance, blood counts, and liver and kidney function tests
(Supplementary Fig. 7c and Supplementary Tables 1 and 2). Cbi
did not affect vitamin B12-dependent functions, as indicated by
normal serum homocysteine and methylmalonic acid concentra-
tions in Cbi-treated mice (Supplementary Table 1).
Oxidative stress may activate PKG1 in a cGMP-independent
fashion, presumably via cysteine 43 oxidation, although the
significance of PKG1 redox regulation in vivo is
controversial40,41. We found a small and similar amount of
cysteine 43-oxidized, cross-linked PKG1 dimer in the aortas of
wild type and Prkg1RQ/+ mice, with no effect of Cbi on dimer
amount (Supplementary Fig. 7d). Treating human SMCs with
high concentrations of H2O2 (i.e., 100–200 μM) induced cysteine
43 oxidation of PKG1α, but it did not increase VASP
Fig. 1 Development of age-related pathologic changes in the thoracic aortas of Prkg1RQ/+ mice. a, b PKG activity was measured in aortic extracts from wild
type (WT, blue symbols) and Prkg1RQ/+ (RQ/+, red symbols) mice using a synthetic peptide (a n= 2 M+ 6 F mice per genotype) or by assessing
phosphorylation of vasodilator-stimulated protein (VASP) using a phospho-Ser239-specific antibody (b n= 5 M+ 6 F mice per genotype). The PKG
inhibitor DT was added as indicated. Three wild type and three mutant aortas are shown in the western blot. c, d Systolic blood pressure measured by
telemetry over 24 h in 4-month-old WT and Prkg1RQ/+ mice (n= 4 male mice per genotype), and mean arterial pressure (MAP) averaged separately
during rest (7 a.m.–7 p.m.) and activity (7 p.m.–7 a.m.). e Ultrasound images of thoracic aortas of 12-month-old WT and Prkg1RQ/+ mice. Measurements
were performed at end-diastole, indicated by an arrowhead below the ECG (A= aortic root; B= ascending aorta, and C= aortic arch; RPA=right
pulmonary artery; LSA=left subclavian artery). f Diameter of the aortic root, ascending aorta, and aortic arch in 12-month-old WT and Prkg1RQ/+ mice (n=
6 M+ 7 F mice per genotype). g–j Elastin fiber breaks (g), SMC density (h), SMC apoptosis (i), and media collagen content (j) of ascending aorta cross-
sections from the animals in panel f were assessed by Van Gieson’s (g), hematoxylin/eosin (h), TUNEL (i), and Masson-Trichrome (j) stains (×80 with
25 µm scale bars in h, i and ×40 with 50 µm bars in g, j). Arrows in g and i point to elastin fiber breaks and some TUNEL-positive nuclei, respectively.
Collagen content (j, blue) of aortic media was quantified using ImagePro (A= adventitia; excluded). In panels g and h n= 5 M+ 5 F mice and in panels
iand j n= 3 M+ 3–4 F per genotype. Graphs show means ± SD; *p < 0.05, **p < 0.01, ***p < 0.001 for the indicated comparisons by two-sided Student’s
t-test (panels b, f, h, i, j), Mann–Whitney test (g), or two-way ANOVA (panels a, d; #p < 0.05 for comparison of basal activity in WT versus RQ/+; +p <
0.05 and +++p < 0.001 for comparison of the same condition in the absence versus presence of DT2). In panels g, h, ns= non-signficant. Source data are
provided as a Source Data file
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Fig. 2 Gene expression changes, Nox4 upregulation, oxidative stress, and increased MMP activity in Prkg1RQ/+ aortas. a, b Relative mRNA expression in
aortas of 4-month-old PKG1RQ/+ mice compared to wild-type mice: smooth muscle α2-actin (Acta2); myosin heavy chain-11 (Myh11); transgelin (Tagln);
myocardin (Myocd); TGF-β1 (Tgfb1); plasminogen activator inhibitor-1 (Serpine1); connective tissue growth factor (Ctgf); collagen3-α1 (Col3a1); elastin (Eln);
lumican (Lum); decorin (Dcn); and NADPH oxidase-2 and -4 (Nox2, Nox4). Genes of interest were normalized to 18S rRNA and the mean ΔCt of WT mice
was assigned a value of one (n= 3–4 M+ 3–4 F mice per genotype). c H2O2 production of aortic SMCs isolated from WT (in blue) and PKGRQ/+ (in red)
mice measured over time by Amplex Red fluorescence. d–g Oxidative stress markers measured in aorta and serum of 8- to 12-month-old WT and
PKGRQ/+ mice. DNA oxidation was assessed by immunohistochemical staining of 8-OH-deoxyguanosine (d: arrows point to examples of brown nuclei
counted as positive; scale bar 50 μm, n= 2 M+ 3 F mice per genotype). Lipid peroxidation was assessed by measuring aorta malondialdehyde (MDA)
content using thiobarbituric acid (e, n= 2 M+ 5 F mice). Ascorbyl radical was measured in serum by electron paramagnetic resonance (f, n= 2 M+ 5 F
mice). Protein carbonyl groups were detected by OxyBlotTM after derivatization of aortic extracts with 2,4-dinitrophenylhydrazine (DNPH); non-derivatized
extracts served as control and reprobing with a β-actin antibody showed equal loading (g, ImageJ quantification for n= 2 M+ 2 F mice per genotype
below). h JNK activation was assessed on western blots of aortic extracts using a phospho-specific antibody, and was normalized to β-actin (ImageJ
quantification for n= 4 M+ 6 F mice per genotype below). i, j Metalloproteinase (MMP) activity was assessed in aortic extracts by gelatin zymography
(i, n= 1 M+ 2 F mice per genotype) and measured using fluorescently labeled elastin as a substrate (j, n= 2 M+ 4 F mice per genotype; conditioned
medium from MDA-MB231 cells served as positive control). Graphs (a, g) show means ± SEM, other plots means ± SD; *p < 0.05, **p < 0.01, ***p < 0.001
for the indicated comparisons by one-sample t-test (panels a, b, g), two-sided t-test (e, f, h, j), or Mann–Whitney test (d). Source data are provided as a
Source Data file
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phosphorylation, confirming our previous observation that
cysteine 43 oxidation does not activate the kinase (Supplementary
Fig. 7e)41.
Gene expression profiling in Nox4-transgenic and -knockout
mice previously identified Tgfb1 and hypoxia-inducible factor-1α
(Hif1a) as potential downstream targets of Nox442–44. We found
increased expression of Nox4, Tgfb1 and its target Ctgf, as well as
Hif1a and its target vascular endothelial growth factor-A (Vegfa)
in the aortas of 12-month-old Prkg1RQ/+ mice compared to wild-
type littermates (Fig. 4g). Cbi treatment of the mutant mice
reduced all five transcripts, with Hif1a and Vegfa mRNAs
reaching levels similar to those observed in wild-type mice
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(Fig. 4g). Cbi suppression of Nox4 mRNA in the mutant mice
may be explained by redox regulation of the Nox4 promoter45.
Since dysregulation of the Hif-1α/Vegfa and Tgfb1/Ctgf pathways
has been linked to aortic aneurysm progression9,28,46,47, these
Nox4 target genes likely contribute to aortic pathology in
PKG1RQ/+ mice.
Transverse aortic constriction-induced aortic rupture in young
Prkg1RQ/+ mice. To determine if increased wall stress affected
the aortas of young Prkg1RQ/+ mice, we subjected 4-month-old
mice to transverse aortic constriction (TAC)48, which increased
blood pressure in the ascending aorta in WT and Prkg1RQ/+
similarly (Fig. 5a, Supplementary Fig. 8a, b). Within 2 weeks of
TAC, 36% of Prkg1RQ/+ mice succumbed to aortic rupture—with
hemothorax found on necropsies—while none of the WT mice
died (Fig. 5b, Supplementary Fig. 8c). Surviving mice of both
genotypes showed similar pre-stenotic aortic dilation (Fig. 5c,
Supplementary Fig. 8d). TAC induced severe aortic wall pathol-
ogy in young Prkg1RQ/+ mice, with thinning of the media, elastin
fiber breaks, loss of SMCs, increased SMC apoptosis, DNA oxi-
dation, and media collagen content; none of these changes
occurred in aortas from WT mice (Fig. 5d–i, Supplementary
Fig. 8e–f). To assess if oxidative stress contributed to the TAC-
induced changes in the Prkg1RQ/+ mutants, we treated mice with
the antioxidant N-acetylcysteine (NAC) for 4 weeks prior to and
2 weeks after TAC. We purposefully chose an antioxidant that
was structurally and mechanistically unrelated to Cbi. NAC
treatment largely prevented TAC-induced aortic pathological
changes, including media thinning, and reduced oxidative stress
in Prkg1RQ/+ mice, with no obvious effect in wild type mice
(Fig. 5d–i, Supplementary Fig. 8e, f). The survival of NAC-treated
mutant mice subjected to TAC did not differ from that of
untreated mice, and NAC did not affect pre-stenotic aortic dila-
tion or aortic pressure gradients after TAC surgery.
Discussion
We identified several mechanisms whereby constitutive PKG1
activation induces thoracic aortic pathology (Fig. 5j): (i) JNK is
activated, up-regulating NOX4, and leading to increased oxidative
stress, which further increases JNK activation; (ii) oxidative stress
and JNK activation initiate SMC apoptosis and MMP-2 activation,
causing elastin fiber degradation; (iii) impaired SMC proliferation
and increased SMC apoptosis lead to SMC depletion; and (iv)
increased TGF-β expression and target gene upregulation may
contribute to aortic pathology, at least in late stages of aneurysm
progression9,28,49. NOX4 upregulation leads to increased Hif-1α
and Vegfa expression, and dysregulated HIF-1α /VEGF signaling
has been observed in TAAD and linked to aortic aneurysm
progression43,44,46,47,50,51.
In contrast to decreased SMC contractile proteins typically
found in familial TAAD2,5,6,52, PKG1RQ-expressing SMCs
showed an increase in contractile markers, consistent with the
identified role of PKG1 in SMC phenotypic modulation12–15. Our
data suggest that PKG1RQ-expressing SMCs are locked in a low
proliferative, contractile state, which interferes with vascular
repair and aortic wall homeostasis.
Increased reactive oxygen species and JNK activation leading to
MMP upregulation have been implicated in several types of
TAAD and abdominal aortic aneurysms7,8,31,52–54. However,
anti-oxidants and MMP inhibitors have had disappointing results
in treatment of aortic aneurysms, which may be because of low
systemic drug concentrations and/or low target affinities1,55,56.
Cbi was highly effective in preventing age-related aortic pathol-
ogy, including aortic dilation in the Prkg1RQ/+ mice, and it
reduced oxidative stress markers in the aorta. Cbi reacts very
quickly with O2− and has a favorable toxicity profile39, suggesting
it could retard onset of other forms of TAAD associated with
oxidative stress52,53,57. NAC was effective in ameliorating aortic
wall injury after TAC, but its effect on mortality was limited,
perhaps due to mechanical factors contributing to aortic rupture.
Studies to confirm a role of NOX4 in aortic disease could be
pursued by crossing Prkg1RQ/+ mice with Nox4 knockout mice;
however, Nox4-deficient mice exhibit vascular abnormalities—
including endothelial dysfunction and apoptosis—which would
confound interpretation of results58,59. Basal NOX4-derived
H2O2 appears to have some vascular-protective effects, while
increased NOX4 expression can exert both adverse and protective
actions in cardiovascular disease models43,60–62.
Our data identify constitutive PKG1 activation as a cause of
increased oxidative stress and vascular damage. The clinical sig-
nificance of this finding reaches beyond the small number of
people carrying the activating PRKG1,p.Arg177Gln mutation,
because widespread use of PKG1-activating agents for a variety of
disorders10 may have unexpected long-term consequences on
aortic wall homeostasis.
Methods
Generation of PKG1RQ knock-in mice. All animal experiments complied with
ethical guidelines for the use of animals in research according to policies of the
University of California, and were approved by the Institutional Care and Use
Committee of the University of California, San Diego. Mice were housed in groups
of 2–4 in a temperature-controlled environment with 12/12 h light/dark cycle. To
generate PKG1RQ knock-in mice, we used KOD Xtreme Hotstart polymerase
(EMD Millipore Corporation, Billerica, MA, USA) with 129S1 embryonic stem cell
genomic DNA as a template to amplify prkg1 exon III, a 3.4-kb fragment of 5′-
flanking sequence, and a 3.1-kb of 3′-flanking sequence. The arginine to glutamine
mutation was generated in exon 3 by overlapping extension PCR using the primers
originally used to amplify the 3′ fragment, and the following mutagenesis primers:
5′-CTGTACCCAGACAGCGACCGTCAAGAG-3′ and 5′-GGTCGCTCTCTGG
GTACAGTTGTAAAG-3′. A targeting construct was assembled with the fragments
Fig. 4 Reduction of oxidative stress and prevention of age-dependent aortic pathology in cobinamide-treated PKGRQ/+ mice. Starting at 6 months of age,
wild type (WT, in blue, n= 5 M+ 4 F mice) and Prkg1RQ/+ mice (RQ/+, in red, n= 5 M+ 7 F mice) received 1 mM histidyl-cobinamide (Cbi, cross-
hatched bars) in the drinking water for 6 months; controls were left untreated (open bars, WT n= 7 M+ 7 F, and RQ/+n= 9 M+ 11 F mice). All mice
were analyzed by ultrasound (d); at least five mice per group (both genders) were analyzed in the other panels. a DNA oxidation assessed by
immunohistochemical staining with an antibody for 8-OH-deoxyguanosine; brown nuclei in the medial layer were counted (arrows show examples of cells
counted as positive). b Protein carbonyl groups detected by OxyBlotTM in aortic extracts as described in Fig. 2g and quantified by densitometric scanning.
c SMC apoptosis assessed by TUNEL staining; only TUNEL-positive nuclei in the media were counted. d Diameter of the aortic root, ascending aorta, and
aortic arch were measured by ultrasound at the age of 12 months. e SMC density measured by counting SMC nuclei on hematoxylin/eosin-stained
sections. f Elastin fiber breaks (arrows show examples) quantified on Van Giessen-stained cross-sections of the ascending aorta. Scale bars are 25 µm.
g mRNA expression in aortas of 12-month-old mice treated for 1 month with 1 mM Cbi in the drinking water (or left untreated, five female mice per group):
TGF-β1 (Tgfb1); connective tissue growth factor (Ctgf); hypoxia-inducible factor-α (Hif1a); vascular endothelial growth factor-A (Vegfa); NADPH oxidase-4
(Nox4), and hypoxanthine phosphoribosyltransferase (Hprt). Genes were normalized to 18S rRNA and the mean ΔCt of WT mice was assigned a value of
one. Boxplots show median and interquartile range with whiskers indicating the total range, and the graph in b shows means ± SD (*p < 0.05, **p < 0.01,
and ***p < 0.001 for the indicated comparisons by two-way ANOVA). Source data are provided as a Source Data file
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on either side of a Frt-flanked neomycin cassette (Supplementary Fig. 1b), and all
PCR products were sequenced. The linearized construct was electroporated into
129S1 embryonic stem cells, and G418-resistant clones were screened by PCR using
the primers 5′-ATCCTCATCCCCACAACAG-3′ and 5′-TCTTTTGTGACTTCA
ACCTTCC-3′. Homologous recombination was confirmed by Southern blot ana-
lysis of positive clones, using probes outside of the targeting construct (Supple-
mentary Fig. 1b, c). A positive clone with normal chromosome analysis in 20
metaphase spreads was injected into C57Bl/6 blastocysts to establish chimeric mice.
Male chimeric mice were mated to C57BL/6J females and agouti pups were
screened for the presence of the mutated allele. To remove the neomycin cassette,
heterozygous mice were mated with flip recombinase-expressing mice in a 129S4
background (JAX mouse stock #003946). The removal of the neomycin cassette
was confirmed, and subsequent genotyping was performed by PCR using tail DNA
template with the following primers: 5′-ATAATGCCCAAGGGTTGGAG-3′ and
5′-AAAGGCTGGGGAAAGGTAGG-3′ (primers F1/R1 in Supplementary Fig. 1d).
Additional screening was performed by restriction fragment length polymorphism;
genomic DNA was PCR amplified with the primers 5′-AAGCTCCACGTTTTC
AGC-3′ and 5′-GATATCATCCCCAGGCTTTTG-3′, and the 531 bp PCR product
was digested with NciI. The wild-type allele is cut into 188 and 343 bp fragments
and the mutant allele remains uncut (Supplementary Fig. 1e). To produce mice in
an inbred 129S background, offsprings from matings with 129S4 flip recombinase-
expressing females were backcrossed for at least three generations with
WT; NAC
j
WT; NAC
a
b
*** **
RQ/+; NAC
Ascending aorta
(Pre&post TAC)
******
M
ed
ia
 th
ick
ne
ss
 (μ
m
)
%
 T
UN
EL
-p
os
itiv
e 
ce
lls
in
 th
e 
m
ed
ia
%
 8
-O
H-
dG
uo
-p
os
itiv
e 
ce
lls
in
 th
e 
m
ed
ia
Co
lla
ge
n 
co
nt
en
t
(%
 ar
ea
 of
 m
ed
ia)
c
e
**
g
d
h i
f
WT RQ/+ WT WTRQ/+ RQ/+
El
as
tin
 b
re
ak
s 
pe
r m
m
2
SM
C 
nu
cle
i p
er
 m
m
2
Pe
rc
en
t s
ur
vi
va
l
D
ia
m
et
er
 (m
m)100
200 6000 10
8
6
4
2
0
4000
2000
0
150
100
50
0
15
0.3
0.2
0.1
0.0
10
5
0
2.5 80
70
60
50
40
30
2.0
1.5
1.0
0.5
0.0
80 WT (n = 19)
WT; NAC (n = 15)
RQ/+ (n = 22)
RQ/+ NAC (n = 17)
60
30
0
0 5 10
Time (d)
15 WT NAC: – + – +
Control WT RQ/+
NAC: – + – +
WT RQ/+
NAC: – + – +
WT RQ/+
NAC: – + – +
WT RQ/+
NAC: – + – +
WT RQ/+
NAC: – + – +
WT RQ/+
+NAC
RQ/+ WT RQ/+
Survival after TAC 
Elastin fiber breaks
(post TAC)
DNA oxidation
(post TAC)
Media collagen content
(post TAC)
SMC density
(post TAC)
Apoptosis of media cells
(post TAC)
Media thickness
(post TAC)
RQ/+; NAC RQ/+; NACWT; NAC
Constitutively-active PKG1RQ
JNK
activation
Proliferation
Apoptosis
SMC loss Elastic fiber degradation Media fibrosis
+ Mechanical stress
Aortic dissectionAortic dilatation Aortic mediadegeneration
NOX4
Cbi
NAC
Oxidation
stress
MMP
activity
Contractile
proteins
HIF-α/VEGF
TGF-β/CTGF
A
B
LSARPA
WTPre-TAC
B
A
Post-TAC WT
TAC
RPA
LSA
26 WM
26 WM-2
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11389-1 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3533 | https://doi.org/10.1038/s41467-019-11389-1 | www.nature.com/naturecommunications 9
129S1/SvImJ mice (JAX mouse stock #002448). These mice were used for all
expreriments, except in the TAC experiments shown in Fig. 5 and Supplementary
Fig. 8. Mice used for TAC experiments were backcrossed for at least eight gen-
erations into a C57BL/6NHsd background (Envigo catalog #044); this was done
because cardiac outcomes after TAC have been well characterized in this back-
ground, and in male mice there is no evidence of heart failure 14 days after TAC48.
Except for TAC, all experiments were performed with both male and female lit-
termates from multiple litters, and results are shown for mixed gender, unless
stated otherwise.
Randomization and drug treatment of mice. At the time of weaning, male and
female littermates were separated and randomly assigned to new cages. At the age
of 6 months (aging studies) or 10–14 weeks (TAC studies), matched cages con-
taining mice born within a 3-week period were randomly assigned to treatment
versus vehicle groups. For aging studies, some mice received 1 mM trihistidyl-
cobinamine (Cbi) in the drinking water, starting from the age of 6 months until
12 months. For gene expression studies, mice were treated with 1 mM Cbi for one
month only, from 11 to 12 months of age. For TAC studies, some mice received
1 mg/mL NAC in the drinking water starting 4 weeks before until 2 weeks after the
surgery. The drugs were dissolved freshly each week and filter-sterilized; fluid
intake was monitored weekly. The Cbi dose was calculated to be 50 mg/kg/day, and
the NAC dose was 500 mg/kg/day. Aquohydroxyl–cobinamide was synthesized
from cobalamine by removal of the 5,6-dimethyl-benzimidazol ring; trihistidyl-
cobinamide was obtained by adding three molar equivalents of L-histidine to the
aquohydroxyl-cobinamide63. Purity of the drug was >95% by high-pressure liquid
chromatography.
Telemetry blood pressure recordings. Blood pressures were measured on con-
scious 4-month-old mice using a telemetry blood pressure recording system (Data
Sciences International, Ponemah; PA-C10 pressure transmitter). Mice were anes-
thetized with isoflurane (1.5%), and a 20–25 mm midline incision was made ver-
tically at the ventral throat area. The PAC-10 transmitter catheter was introduced
into the left carotid artery and the tip was advanced into the thoracic aorta. Data
were recorded for 3 days, after a 2-week post-operative recovery period.
Transthoracic echocardiography. Prior to echocardiography, a depilatory cream
was applied to the anterior chest wall to remove hair. Mice were anesthetized with
5% isoflurane for 15 s and then maintained at 0.5% throughout the echocardio-
graphy examination. Small needle electrodes for simultaneous electrocardiogram
were inserted into one upper and one lower limb. Transthoracic echocardiography
was performed using the FUJIFILM VisualSonics Inc., Vevo 2100 high-resolution
ultrasound system with a linear transducer of 32-55 MHz. Measurements of aortic
diameters were recorded during end-diastole at the aortic root, ascending aorta,
and aortic arch; they were performed by a single, highly experienced operator, who
was blinded to genotype and treatment of the mice. Bland Altman analyses were
performed to determine inter- and intra-observer variability of echo measurements
(Supplementary Fig. 9). Measuring the diameter of the ascending aorta, the average
of the differences between two observers was −0.061 mm (with 95% limits of
agreement between −0.18 and 0.06 mm), and the average of differences between
two observations by the same observer were 0.024 mm (with 95% limits of
agreement between −0.12 and 0.17 mm).
Arterial ring isometric tension measurements. Isometric tension in aortas was
measured as previously described64, with minor modifications. Thoracic aortas
were dissected in Krebs–Henseleit solution, cleaned of any adherent connective
tissue, and cut into 1.5–2 mm segments. Rings with intact endothelium were
mounted in a wire myograph over 40 μm wires, set at a resting tension of 0.5 g, and
allowed to equilibrate at 37 °C for 45 min with intermittent washes every 15 min.
After equilibration, aortas were treated with 40 mMK+-solution. For vascular
relaxation by acetylcholine (Sigma) or 8-(4-chlorophenylthio)cGMP (8-CPT-
cGMP; BioLog), each aortic ring was pre-contracted to generate ~0.15 g contrac-
tion by treatment with prostaglandin –F2α (PGF2α 2–8 µM; Thermo-Fisher). The
degree of relaxation was calculated as a percent of PGF2α-induced contraction.
Reagent sources and catalog numbers are summarized in Supplementary Table 3.
PKG1 purification and activity assays. Wild type and mutant PKG1RQ were
expressed with N-terminal FLAG epitope tags in transiently transfected 293T cells
(ATCC, CRL3216), purified with anti-FLAG beads and eluted with FLAG peptide,
and kinase activity assays were performed41. Kinase activity in SMC and aortic
extracts was measured using an optimized peptide (TQAKRKKSLAMA, 30 µM)
in the presence of 1.25 µM protein kinase inhibitor peptide (PKI) to inhibit cAMP-
dependent protein kinase65. Assays were performed with [γ-32PO4]ATP
(1.3 Ci/mmol; 50 µM) in the presence and absence of 3 µM cGMP, and were linear
with time and protein concentration. In some assays, the PKG-specific inhibitory
peptide DT2 was included at 10 μM.
Western blotting. Following anesthesia with ketamine (100 mg/kg) and xylazine
(10 mg/kg) by intraperitoneal injection, mice were exsanguinated and perfused
with ice-cold phosphate-buffered saline (PBS) containing protease inhibitor
cocktail (Calbiochem #539131). Aortas were excised, cleaned from surrounding
tissue, and snap-frozen in liquid nitrogen within 15 min of euthanasia. Frozen
aortas were pulverized and sonicated (3 × 10 s) in ice-cold RIPA buffer (50 mM
NaCl, 50 mM Tris-HCl, pH 8, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate)
supplemented with 1 mM NaF, 1 mM β-glycerolphosphate, and protease inhibitor
cocktail. Western blots were developed with primary antibodies specific for PKG1
(1:1000; Cell Signaling Technology; 3248, see Supplementary Table 4), VASP-
phospho-Ser259 (1:1000; Cell Signaling Technology; 3114), GAPDH (1:1000; Cell
Signaling Technology; 2118), β-actin (1:5000; Santa Cruz Biotechnology; 47778),
and JNK-phospho-Thr183/Tyr185 (1:1000; Cell Signaling Technology; 9251). Blots
were developed and visualized with enhanced chemiluminescence using LI-COR
Odyssey (with ImageStudio, V5) or with film in the linear range of exposure (with
densitometry scanning using ImageJ (V1.51). Protein carbonyl groups (aldehydes
and ketones) were detected using the OxyBlotTM Protein Oxidation Detection Kit
(Millipore EMD; S7150). Unprocessed scans of blots are provided in the Source
Data file.
Histomorphometric studies. Following anesthesia with i.p. ketamine (100 mg/kg)
and xylazine (10 mg/kg), mice were perfusion-fixed with 10 mL of 4% paraf-
ormaldehyde for 3 min under physiological pressure. Thoracic aortas were excised
and further fixed overnight. Paraffin-embedded ascending aortas were cross-
sectioned into 5-µm-thick sections, which were stained with haematoxylin and
eosin (to count SMC nuclei), Van Gieson elastin stain (to detect elastin fiber
breaks), and Masson’s Trichrome stain (to quantify collagen), following standard
protocols. Slides were scanned with a Hamamatsu NanoZoomer 2.0 HT System
and analyzed using Digital Pathology NDP.view2 software. The images were
captured at ×10, ×40, and ×80 magnification for histomorphometric analyses66.
The thickness of the aortic media was measured using a straight-line tool at four
different points (at 0°, 90°, 180°, 270°) on two different sections, and the mean was
reported. SMC nuclei and elastin fiber breaks were counted manually at ×40
magnification, on five non-overlapping areas of aortic media measuring 0.025 µm2
each; means were calculated and expressed per mm2. Collagen content of the media
area was measured at ×10 magnification on Masson’s Trichrome-stained cross-
sections using ImagePro Premier software (V 9.0, Media Cybernetics).
Fig. 5 TAC-induced severe aortic pathology and death from aortic rupture in young Prkg1RQ/+ mice. a Aortic arch by ultrasound imaging before and
2 weeks after TAC in a wild-type mouse (A= aortic root; B= ascending aorta; RPA=right pulmonary artery; LSA=left subclavian artery). b Survival of male
wild type (WT, in blue) and PKG1RQ/+ (RQ/+, in red) mice after TAC (n= 19 WT and n= 22 RQ/+). Some animals received N-acetylcysteine (NAC) for
4 weeks before and 2 weeks after TAC (n= 15 WT and n= 17 RQ/+). Only mice surviving 24 h after surgery were included, euthanized 14 days after
surgery. **p < 0.01 by log-rank (Mantel–Cox) test for the indicated comparison. c Diameter of ascending aortas before and 14 days after TAC, measured in
surviving WT and Prkg1RQ/+ mice (n as in panel b, ***p < 0.001 by two-way ANOVA). d Media thickness measured on cross-sections of ascending aortas
in surviving mice. e–g Elastin fiber breaks, SMC density, and apoptosis of media cells assessed on ascending aorta cross-sections of mice euthanized
14 days after TAC surgery (scale bars 25 μm; arrows show examples of elastin fiber breaks and TUNEL-positive nuclei). h DNA oxidation assessed by
staining for 8-OH-deoxyguanosine in nuclei of media cells. i Media collagen content assessed on Masson–Trichrome stains. Boxplots in d–i show median
and interquartile range with whiskers indicating the total range, for n= 6 male mice per group; *p < 0.05, **p < 0.01, ***p < 0.001 for the indicated
comparisons by two-way ANOVA. Source data are provided as a Source Data file. j Schema summarizing consequences of mutant PKG1RQ expression in
the aorta. PKG1 activates JNK causing increased H2O2 production from NOX4 upregulation; oxidative stress further enhances JNK activation, activates and
upregulates MMPs via JNK, and MMPs degrade elastin fibers. PKG1 activation causes SMC loss, in part via JNK activation and oxidative stress. PKG1
increases expression of contractile proteins, HIF-1α/VEGF, and TGF-β/TGF-β target genes; the latter promote aortic media fibrosis, which may be
compensatory. Aortic media degeneration leads to age-dependent aortic dilation, and aortic dissections under hypertensive stress. Cobinamide (Cbi) or
N-acetylcysteine (NAC) treatment reduce oxidative stress and JNK activation, preserving aortic media integrity
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Histomorphometric measurements were confirmed by an investigator who was
blinded to the genotype and treatment group of the mice.
Immunohistochemical staining of aortic sections. Terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end-labeling (TUNEL) of deparaffinized
aortic sections was performed using the Apoptag Peroxidase In-situ Apoptosis
Detection Kit (Millipore EMD; S7100) according to the manufacturer’s instruc-
tions. For 8-OH-dGuo staining of deparaffinized sections, antigen retrieval was
done by placing slides into boiling 10 mM sodium citrate buffer, pH 6, and letting
them cool for 30 min. The sections were treated with RNase A (100 µg/mL) in
10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.4 M NaCl at 37 °C for 1 h, rinsed, treated
with proteinase K (10 µg/mL) in phosphate-buffered saline (PBS) at room tem-
perature for 7 min, and permeabilized with 0.2% Triton X-100 for 15 min. Samples
were blocked in 2% BSA/PBS, and incubated in anti-8-OH-dGuo (1:50 dilution in
1% BSA/PBS), followed by a goat anti-mouse horseradish peroxidase-coupled
secondary antibody (1:100; Jackson Immunoresearch). Slides were developed using
3,3-diaminobenzidine substrate (Vector Laboratories) and counterstained with
methyl green.
Dihydroethidium staining of aortas. Ascending aortas were dissected, and
immediately immersed in 10 µM dihydroethidium (Life Technologies; C10422)
solution in PBS and incubated for 30 min at 37 °C. The tissue was rinsed ×4 in PBS,
placed in Tissue-Tek OCT compound (Miles Laboratories), and snap-frozen in
liquid nitrogen. Cryosections were fixed in 4% paraformaldehyde for 15 min at
room temperature, washed in PBS, and counterstained in Hoechst 33342; sections
were imaged within 4 h by fluorescence microscopy.
Quantitative RT-PCR. Aortas were dissected and snap-frozen as described above;
they were pulverized and immersed in Trizol (Molecular Res.Center, TR118). Total
RNA was isolated, reverse-transcribed using iScript cDNA synthesis kit (Bio-Rad),
and PCR was performed using a MX3005P real-time PCR detection system with
Brilliant II SYBR Green Mix (Agilent Technologies) as described67. Primer
sequences are in Supplementary Tables 5 and 6. All primers were intron-spanning
(except for 18S rRNA), and were tested with serial cDNA dilutions. Relative
changes in mRNA expression were analyzed using the comparative 2−ΔΔCt
method, with 18S rRNA and phosphoglycerate kinase-1 serving as internal
controls68.
SMC culture and adenovirus infection. Murine aortic SMCs were isolated from
the aortas of 8-12 week-old wild type and PKG1RQ/+ mice and were cultured in
Smooth Muscle Basal Media (SmBM) containing 20% FBS, pyruvate, HEPES, L-
glutamine, penicillin/streptomycin, and growth factors (SmBM Bullet kit; CC-4149
from Lonza), as previously described69. Two independent cell isolates from wild type
and PKG1RQ mice were used at passage one. Human primary aortic SMCs were
purchased from Lifeline Cell Technology (Frederick, MD, FC-0015) and cultured in
VascuLife Basal Medium supplemented with recombinant epidermal growth factor,
insulin, and fibroblast growth factor-b, ascorbic acid, L-glutamine, 20% FBS, genta-
mycin, and amphotericin (Vasculife SMC LifeFactors kit; LS-1040 from Lifeline
Technologies). Human SMCs were used at passages 3–6. Adenovirus was generated
using the ViraPower Adenoviral Expression System (Thermo Fisher)67. Human
SMCs were infected with virus expressing wild type or mutant human PKG1α
(containing the R177Q mutation); the MOI was 3–10 and titrated to produce wild
type and mutant kinase at 2–3-fold the level of endogenous PKG1 at 72 h post
infection. For Nox4 over-expression, human SMCs were infected with virus
expressing murine Nox4 to increase H2O2 production to a level comparable to that
induced by PKG1RQ. For knock-down of NOX2 and NOX4, SMCs were infected
with adenovirus expressing shNOX2 or shNOX4 oligomers (downstream of the U6
promoter) at an MOI of 100; H2O2 production and NADPH oxidase activity assays
were performed 48 h later (as described below).
Nox4 promoter activity assay. A 1707bp fragment of the Nox4 promoter region
5′ to the translational start site was cloned from mouse genomic DNA using KOD
Hot Start DNA Polymerase (Millipore) and the following primers: 5′-GCTCTC
GAGCTTTGCAGGCTCAGGCTC-3′ and 5′-GGTCCATGGCGCCGGCGCGGG
GAGTGCT-3′. The PCR product was inserted into pGL3 (Promega) using XhoI
and NcoI sites, and sequenced. C3H/10T1/2 cells (ATCC, CCL226) were trans-
fected with lipofecamine 2000, and luciferase activity was measured using a single
vial luminometer13.
SMC immunofluorescence staining. SMCs were cultured on glass coverslips and
fixed in 4% paraformaldehyde. For 8-hydroxydeoxyguanosine (8-OH-dGuo)
staining, cells were treated with RNase A and proteinase K as described above for
tissue sections. Cells were permeabilized with 0.2% Triton X-100 in PBS and
blocked with 2% BSA in PBS (8 min and 1 h, respectively, at room temperature).
Cells were incubated with the anti-8-OH-dGuo antibody (1:100; Abcam, ab26842)
in 1% BSA in PBS overnight at 4 °C. Apoptotic cells were stained with anti-cleaved
caspase-3 antibody (1:100; Cell Signaling Technology #9664) in 1% BSA in PBS
overnight at 4 °C. To label cells in the S phase, cells were incubated with 200 μM 8-
Br-deoxyuridine (BrdU; Sigma) for 48 h, fixed in paraformaldehyde, and per-
meabilized with 0.2% Triton X-100 as above. After rinsing with PBS, cells were
incubated with DNAse I (Sigma) for 30 min at 37 °C and blocked with 2% BSA in
PBS for 1 h, prior to incubation with anti-BrdU antibody (1:200, Sigma) for 1 h at
room temperature. After washing in PBS, cells were incubated with a Texas Red-
conjugated secondary antibody (1:100; Jackson Immunoresearch), and nuclei were
counterstained with Hoechst 33342 (Thermo Fischer Scientific). Images were
analyzed with a Keyence BZ-X700 fluorescence microscope.
Amplex Red and NADPH oxidase assays. Primary murine SMCs isolated from
wild type or PKG1RQ/+ aortas, and human SMCs infected with control, wild type,
or mutant PKG1RQ virus, were seeded at 4 × 104 cells/well in 96-well plates, and
H2O2 production was measured using an Amplex Red/Hydrogen Peroxide/Per-
oxidase Assay Kit (Thermo Fischer Scientific). Cells were incubated 16 h later in
0.1 mL of reaction mixture containing 50 μM Amplex Red and 0.1 units/mL
horseradish peroxidase. Fluorescence was measured every min in a BioTek Synergy
2 plate reader, using 540 nm excitation and 590 nm emission wavelengths.
To measure NADPH oxidase activity by lucigenin-enhanced
chemiluminescence, SMCs were homogenized in PBS with 1 mM EDTA and
protease inhibitor cocktail (Calbiochem #539131), and supernatants were obtained
after centrifugation at 750g for 5 min. The lucigenin assay was performed in 50 mM
phosphate buffer, pH 7.0, 1 mM EGTA, 150 mM sucrose, with 5 µM lucigenin, and
was started by the addition of 100 µM NADPH52. Photon emission was measured
every second for 5 min in a luminometer, and activity (after subtraction of a buffer
blank) was expressed as relative luminescence units per mg protein.
The following NOX2 and NOX4 shRNAs were expressed from adenoviral
vectors: shNox2 (sense) 5′-GATCGAG-TGGTGTGTGAATGCCAGATTCA
AGAGATCTGGCATTCACACACCACTCTTTTTTG-3′; shNox2 (antisense) 5′-
AATTCAAAAAAGAGTGGTGTGTGAATGCCAGATCTCTTGAATCTGG
CATTCACACACCACTC-3′. shNox4 (sense) 5′-GATCGGAACAAGTGCAATT
TCTAAGTTCAAGAGACTTAGAAATTGCACTTGTTCCTTTTTTG-3′; shNox4
(antisense) 5′- AATTCAAAAAAGGAACAAGTGCAATTTCTAAGTCTCTTGA
ACTTAGAAATTGCACTTGTTCC -3′. Amplex Red and NADPH oxidase activity
assays were performed 48 h after infection of human SMCs.
Thiobarbituric acid-reactive substances assay. Frozen aortas were pulverized
and lysed in 0.15 mL ice-cold RIPA buffer and sonicated three times for 10 s. To
0.1 mL of the tissue lysate, 0.2 mL 10% trichloroacetic acid and 0.3 mL 0.67%
thiobarbituric acid were added, and samples were boiled for 45 min. The thio-
barbituric acid adducts were extracted in butanol and measured using 515 and 553
nm as excitation and emission wavelengths, respectively. Malondialdehyde stan-
dards were from Cayman Chemical.
Ascobyl radical measurement by electron paramagnetic resonance. Murine
blood samples were obtained by cardiac puncture at the time of euthanasia, and
serum samples were kept frozen at −80 °C for up to 4 weeks prior to analysis. EPR
spectra were recorded at room temperature using a MiniScope
MS400 spectrometer (Magnatech). EPR conditions were: modulation amplitude,
0.2 mT; sweep time, 20 s; sweep rate, s−1. Peak amplitude was measured in
arbitrary units.
Matrix metalloproteinase activity assays. Frozen aortas were pulverized and
lysed in 10 mM sodium cacodylate, 150 mM NaCl, 10 mM CaCl2, 1 mM ZnCl2, 1%
Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 0.02% sodium azide, and 2%
DMSO. For zymography, 6 µg of extract protein were subjected to SDS-
polyacrylamide gel electrophoresis under non-reducing conditions in gels con-
taining 1% gelatin16. Gels were washed three times in 2.5% Triton X-100 for 30 min
at room temperature, and incubated in 50 mM Tris-HCl, pH 7.5, 10 mM CaCl2,
200 mM NaCl, and 1 µM ZnCl2 for 18–36 h at 37 °C. Gels were stained with
Coomassie Blue and destained until clear bands showed zones of gelatinolytic
activity. Culture supernatant from MDA-MB231 breast cancer cells served as a
positive control. Total MMP activity in extracts of aortic arches was also measured
with a fluorescently labeled elastin peptide, using the Fluorimetric Sensolyte 520
Generic MMP assay kit (Anaspec; AS-71158) according to the manufacturer’s
instructions, in the linear range of the assay. Results were confirmed using a MMP
Activity Assay Kit from Abcam (ab112146) based on a FRET peptide as MMP
activity indicator.
Transverse aortic constriction. The TAC procedure was performed on 14-20-
week-old wild type and PKG1RQ/+ mice by a single, highly experienced operator,
who was blinded to genotype and treatment of the mice48. Mice were anesthetized
with ketamine (50 mg/kg) and xylazine (5 mg/kg) by intraperitoneal injection and
then received isoflurane (0.75–1.5%) for complete induction of anesthesia. Mice
were ventilated with a pressure ventilator. The chest cavity was entered in the
second intercostal space at the left upper sternal border and the transverse aorta
was isolated between the carotid arteries. Aortic constriction was performed by
tying a 7-0 silk suture ligature against a 27–27.5-gauge needle (according to the
body weight), and the needle was promptly removed to yield a constriction of
about 0.4 mm in diameter. Following the constriction procedure, the chest was
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closed with 6-0 silk sutures. Buprenorphine (0.1 mg/kg, 100 μl/mouse) was given
15–30 min prior to anticipated recovery, and every 12 h for 3 days post-operatively.
Mice were euthanized 14 days after the procedure. Mice dying within 24 h after
TAC surgery were excluded from analyses: 6/40 wild type and 5/44 heterozygous
mice died for a total peri-operative mortality of 13%.
Blood pressure gradient measurements post TAC. To evaluate the stress level
generated by TAC, the pressure gradient between the two carotid arteries was
measured at the end of study (d14). Anesthesia was induced, and mice were
ventilated as described for TAC. Both carotid arteries were exposed and cannulated
with stretched PE 50 catheters connected to fluid-filled transducers. Both carotid
artery pressures were simultaneously recorded and analyzed in LabChart
(ADInstruments).
Statistics. Most data are presented as dot plots with means ± SD or box and
whiskers plots, where the upper and lower margins of the box define the 75th and
25th percentiles, respectively, the internal line defines the median, and the whiskers
show the total range. Bar graphs showing means ± SEM were used for data nor-
malized to a control group (e.g., qRT-PCR results, where the control group was
assigned a value of one) and for Fig. 3, showing averages of at least three inde-
pendent cell culture experiments. Where appropriate (for n > 7), the data were
tested for normality using the D’Agostino-Pearson omnibus normality test, and for
equal variance using an F test (to compare the variances of two groups), or the
Browne and Forsythe test (for three or more groups). For comparison of two
groups, P values refer to unpaired, two-tailed Student’s t-test. For multiple com-
parisons, P values refer to either one-way ANOVA followed by Sidak’s multiple
comparison test, or to two-way ANOVA with Holm–Sidak’s multiple comparison
test (e.g., when determining how the genotype of the mice affected response to drug
treatment or TAC). P < 0.05 was considered statistically significant. When the
assumptions of normal distribution and/or equal variances were not met, a non-
parametric test was chosen (Mann–Whitney test for two groups and
Kruskal–Wallis test for three or more groups). Data analysis was performed using
GraphPad Prism 7 software. The tests employed are described in the figure legends.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data supporting the findings of this study are available within the paper and
its supplementary information files. The source data underlying all graphs and blots in
Figs. 1–5 and Supplementary Figs. 1–8 are provided as a Source Data File. All data are
available from the corresponding author upon reasonable request.
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